What is ZygoFix?
ZygoFix is dedicated to advancing spinal fusion technology with its proprietary zLOCK system. This unique bendable titanium implant is engineered for joint stabilization, aiming to minimize surgical invasiveness and enhance patient recovery. The technology has achieved clinical validation in the European Union, demonstrating efficacy in long-term pain reduction and a lower incidence of complications. The company's focus on the ASC market positions it to capitalize on the growing trend of outpatient surgical procedures.
How much funding has ZygoFix raised?
ZygoFix has raised a total of $2M across 1 funding round:
Other Financing Round
$2M
Other Financing Round (2021): $2M with participation from Agriline Products, Israel Innovation Authority, and Trendlines
Key Investors in ZygoFix
Agriline Products
Agriline Products is an entity that has participated in ZygoFix's funding rounds. Further details on their investment focus are not publicly available.
Israel Innovation Authority
The Israel Innovation Authority is a governmental body dedicated to fostering technological innovation within Israel, supporting startups and established companies through various funding programs and initiatives to drive R&D and commercialization.
Trendlines
Trendlines is an investment group focused on nurturing and investing in early-stage medical and agricultural technologies, aiming to bring innovative solutions to market.
What's next for ZygoFix?
With substantial enterprise-level backing and a recent strategic investment, ZygoFix is poised for accelerated growth and market penetration. The company's next steps will likely involve scaling production of the zLOCK system, expanding its commercial reach, and potentially pursuing further clinical trials or regulatory approvals in new markets. This capital infusion is expected to fuel research and development, further solidifying ZygoFix's position as a leader in innovative spinal stabilization solutions.
See full ZygoFix company page
